Affordable Access

Access to the full text

Convalescent plasma to treat COVID-19

Authors
  • Bloch, Evan M.
Type
Published Article
Journal
Blood
Publisher
American Society of Hematology
Publication Date
Aug 06, 2020
Volume
136
Issue
6
Pages
654–655
Identifiers
DOI: 10.1182/blood.2020007714
PMID: 32761219
PMCID: PMC7414591
Source
PubMed Central
License
Green

Abstract

In this issue of Blood , Hegerova et al report on a study of 20 hospitalized patients with severe or critical coronavirus disease 2019 (COVID-19) who were transfused with convalescent plasma (CP); the authors suggest a favorable, albeit modest, benefit as compared with 20 matched (ie, nontransfused) controls, particularly when transfusion was undertaken within the first 7 days of hospitalization. 1

Report this publication

Statistics

Seen <100 times